phenylalanine has been researched along with evans blue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Antoniu, BA; Balcom, JH; Fernández-del Castillo, C; Keck, T; Warshaw, AL | 1 |
Bailly, B; Day, CJ; Dirr, L; Guillon, P; Haselhorst, T; Jen, FE; Jennings, MP; Mak, J; Spillings, BL; von Itzstein, M | 1 |
2 other study(ies) available for phenylalanine and evans blue
Article | Year |
---|---|
Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Topics: Acute Disease; Animals; Basement Membrane; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Movement; Cells, Cultured; Coloring Agents; Evans Blue; Humans; Interleukin-1; Lung Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neutrophils; Pancreatitis; Peroxidase; Phenylalanine; Protease Inhibitors; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Thiophenes; Trypsin; Tumor Necrosis Factor-alpha | 2002 |
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Topics: Aminopyridines; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Benzodioxoles; Cell Line; Chlorocebus aethiops; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; Evans Blue; Humans; Molecular Docking Simulation; Phenylalanine; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Sulfones; Surface Plasmon Resonance; Vero Cells; Virus Attachment; Virus Replication | 2021 |